Dr. Apolo on Managing Toxicities of Checkpoint Inhibitors in Bladder Cancer
January 19th 2018
Andrea B. Apolo, MD, medical oncologist, chief of the bladder cancer section of the Genitourinary Malignancies Branch, National Cancer Institute, discusses managing immune-related toxicities from checkpoint inhibitors in patients with bladder cancer.